● Recruiting

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Condition: Posttraumatic Headache · Mild Traumatic Brain Injury · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

PhasePhase 2

Planned participants404

Who can joinAll sexes, 18 Years to 50 Years

Healthy volunteersNo

About this study

This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).

This description comes directly from the study's public registry record.

Talk to the study team

Amy Guthrie, RN · 202-924-2729 · amy.guthrie.ctr@usuhs.edu

Always discuss trial participation with your own doctor first.

Locations (4)

Womack Army Medical Center - Fort Liberty	Fort Bragg, North Carolina, United States	Recruiting
University of Pittsburgh Concussion Research Laboratory	Pittsburgh, Pennsylvania, United States	Not Yet Recruiting
William Beaumont Army Medical Center	El Paso, Texas, United States	Recruiting
Madigan Army Medical Center	Tacoma, Washington, United States	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05049057